Esperion Therapeutics
ESPR
#6169
Rank
C$1.22 B
Marketcap
C$5.15
Share price
-1.58%
Change (1 day)
10.03%
Change (1 year)

Esperion Therapeutics (ESPR) - Net assets

Net assets on the balance sheet as of September 2025 : -C$0.63 Billion

According to Esperion Therapeutics's latest financial reports the company has -C$0.63 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Esperion Therapeutics - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$-C$0.56 Billion-7.57%
2023-12-31$-C$0.61 Billion37.36%
2022-12-31$-C$0.44 Billion75.04%
2021-12-31$-C$0.26 Billion104.76%
2020-12-31$-C$0.13 Billion-570.44%
2019-12-31$C$26.05 M-75.82%
2018-12-31$C$0.10 B-64.97%
2017-12-31$C$0.30 B0.14%
2016-12-31$C$0.30 B-22.91%
2015-12-31$C$0.39 B157.11%
2014-12-31$C$0.15 B96.51%
2013-12-31$C$78.86 M-556.1%
2012-12-31$-C$17.3 Million180.67%
2011-12-31$-C$6.17 Million
2002-12-31$C$61.19 M-42.24%
2001-12-31$C$0.10 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Ultragenyx Pharmaceutical
RARE
C$22.32 M-103.58%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$8.36 B-1,441.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$128.61 B-20,725.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$42.76 B-6,958.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
C$0.31 B-151.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
C$0.16 B-126.62%๐Ÿ‡บ๐Ÿ‡ธ USA